Related Experiment Video

Updated: Sep 25, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Regression of established tumors and metastases by potent vascular endothelial growth factor blockade

Jianzhong Huang1, Jason S Frischer, Anna Serur

  • 1Division of Pediatric Surgery, Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.

Proceedings of the National Academy of Sciences of the United States of America
|June 14, 2003
PubMed

Insights

High-affinity blockade of vascular endothelial growth factor (VEGF) eliminates established tumor vasculature, leading to significant tumor regression. This approach shows promise for treating advanced, metastatic cancers.

Area of Science:

  • Oncology
  • Vascular Biology
  • Cancer Therapeutics

Background:

  • Vascular endothelial growth factor (VEGF) drives blood vessel formation in development and cancer.
  • Current VEGF antagonist research focuses on minimal residual disease and preventing new vessel growth (neoangiogenesis).
  • VEGF also maintains the integrity of existing blood vessels through endothelial-vascular mural cell interactions.

Purpose of the Study:

  • To investigate the effect of high-affinity VEGF blockade on established tumor vasculature.
  • To determine if targeting mature vasculature can induce tumor regression in advanced cancer models.

Main Methods:

  • Utilized VEGF-Trap, a high-affinity VEGF antagonist.
  • Administered VEGF-Trap to established xenografts with mature vasculature.
  • Monitored tumor regression and metastatic spread.

Main Results:

  • High-affinity VEGF blockade abolished mature, preexisting tumor vasculature.
  • Vascular eradication led to significant tumor regression.
  • Regression of lung micrometastases was observed.

Conclusions:

  • VEGF plays a critical role in maintaining the integrity of established tumor vasculature, even at low levels.
  • Potent VEGF blockade can eradicate existing vasculature and induce regression in bulky, metastatic cancers.
  • VEGF antagonism represents a potential therapeutic strategy for advanced malignancies.

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics12:09

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...